NutriBand (NTRB) Cash from Operations (2016 - 2026)
NutriBand's (NTRB) quarterly Cash from Operations came in at -$584999.0 in Q3 2026, up 55.46% year-over-year from -$376308.7 in Q3 2025, and down 3.89% quarter-over-quarter from -$563104.0 in Q2 2026.
Powered by 
Analysis
NutriBand (NTRB) Cash from Operations (2016 - 2026) Analysis & Trends
NutriBand has disclosed Cash from Operations across 11 years of filings, most recently posting -$584999.0 for Q3 2026.
- In Q3 2026, Cash from Operations rose 55.46% year-over-year to -$584999.0; the TTM figure through Jul 2026 stood at -$3.6 million (up 25.86% YoY), while the FY2026 annual figure was -$5.1 million, down 10.98% from the prior year.
- Cash from Operations came in at -$584999.0 for Q3 2026 at NutriBand, down from -$563104.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of -$520443.0 in Q4 2022 to a low of -$1.8 million in Q4 2025.
- Average Cash from Operations over 5 years is -$981917.8, with a median of -$908493.0 recorded in 2022.
- Year-over-year, Cash from Operations slumped 1382.25% in 2022 and soared 57.88% in 2026.
- Over 5 years, Cash from Operations stood at -$520443.0 in 2022, then slumped by 104.49% to -$1.1 million in 2023, then advanced by 5.13% to -$1.0 million in 2024, then plunged by 73.57% to -$1.8 million in 2025, then surged by 66.62% to -$584999.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were -$584999.0 in Q3 2026, -$563104.0 in Q2 2026, and -$731830.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 411.00 Mn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 381.80 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -9.79 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | -21.24 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 670.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 56.67 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -19.79 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 51.32 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 | -584,999.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -584,999.00 |
| Apr 30, 2026 | -563,104.00 |
| Jan 31, 2026 | -731,830.00 |
| Oct 31, 2025 | -1.75 Mn |
| Jul 31, 2025 | -1.31 Mn |
| Apr 30, 2025 | -1.34 Mn |
| Jan 31, 2025 | -1.24 Mn |
| Oct 31, 2024 | -1.01 Mn |
| Jul 31, 2024 | -1.54 Mn |
| Apr 30, 2024 | -833,926.00 |
| Jan 31, 2024 | -718,240.00 |
| Oct 31, 2023 | -1.06 Mn |
| Jul 31, 2023 | -995,135.00 |
| Apr 30, 2023 | -749,864.00 |
| Jan 31, 2023 | -814,005.00 |
| Oct 31, 2022 | -520,443.00 |
| Jul 31, 2022 | -908,493.00 |
| Apr 30, 2022 | -744,257.00 |
| Jan 31, 2022 | -1.23 Mn |
| Oct 31, 2021 | -1.21 Mn |